The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres

British Journal of Pharmacology

Volumn 137, Issue 7, 2002, Pages 1125-1133

  More, Julia C A ^a   Troop, Helen M ^a   Jane, David E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

(S) 3 (4 carboxybenzyl)willardiine; 3 CBW; AMPA; Antagonist; GYKI53655; Kainate; Neonatal rat spinal cord

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 3 (4 CARBOXYBENZYL)WILLARDIINE; 3,5 DIHYDROXYPHENYLGLYCINE; 5 FLUOROWILLARDIINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; KAINIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG; 2,3 DIOXO 6 NITRO 7 SULFAMOYLBENZO(F)QUINOXALINE; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; 3-(4-CARBOXYBENZYL)WILLARDIINE; ALANINE; AMINO ACID RECEPTOR BLOCKING AGENT; BENZODIAZEPINE DERIVATIVE; BENZYL DERIVATIVE; DRUG DERIVATIVE; PYRIMIDINONE DERIVATIVE; QUINOXALINE DERIVATIVE; URACIL; WILLARDIINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; DRUG EFFECT; EVOKED RESPONSE; IC 50; MOTONEURON; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VENTRAL ROOT; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; NERVE FIBER; PHYSIOLOGY; SPINAL ROOT; TIME;

ALANINE; ANIMALS; ANIMALS, NEWBORN; BENZODIAZEPINES; BENZYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS; EXCITATORY AMINO ACID ANTAGONISTS; MOTOR NEURONS; NERVE FIBERS; PYRIMIDINONES; QUINOXALINES; RATS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SPINAL NERVE ROOTS; TIME FACTORS; URACIL;

EID: 0036898034     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704957     Document Type: Article

References (47)

1. Agrawal, S.G. & Evans, R.H. (1986). The primary afferent depolarizing action of kainate in the rat. Br. J. Pharmacol., 87, 345-355.
2. Bahn, S., Volk, B. & Wisden, W. (1994). Kainate receptor gene expression in the developing rat brain. J. Neurosci., 14, 5525-5547.
3. Bettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E.S., Moll, C., Borgmeyer, U., Hollman, M. & Heinemann, S. (1990). Cloning of a novel glutamate receptor subunit, GIuR5: Expression in the central nervous system during development. Neuron, 5, 583-595.
4. Blake, J.F., Jane, D.E. & Watkins, J.C. (1991). Action of willardiine analogues on immature rat dorsal roots. Br. J. Pharmacol. Proc., 104, (Suppl) P334.
5. Bleakman, D., Ballyk, B.A., Schoepp, D.D., Palmer, A.J., Bath, C.P., Sharpe, E.F., Woolley, M.L., Bufton, H.R., Kamboj, R.K., Tarnawa, I. & Lodge, D. (1996). Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: Stereospecificity and selectivity profiles. Neuropharmacology, 35, 1689-1702.
6. Bleakman, D. & Lodge, D. (1998). Neuropharmacology of AMPA and kainate receptors. Neuropharmacology, 37, 1187-1204.
7. Bleakman, D., Ogden, A., Ornstein, P. & Hoo, K. (1999). Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurones. Eur. J. Pharmacol., 378, 331-337.
8. Chittajallu, R., Braithwaite, S.P., Clarke, V.R. & Henley, J.M. (1999). Kainate receptors: Subunits, synaptic localization and function. Trends Pharmacol. Sci., 20, 26-35.
9. Clarke, V.R., Ballyk, B.A., Hoo, KH., Mandelzys, A., Pellizzari, A., Bath, C.P., Thomas, J., Sharpe, E.F., Davies, C.H., Ornstein, P.L., Schoepp, D.D., Kamboj, R.K., Collin-Gridge, G.L., Lodge, D. & Bleakman, D. (1997). A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature, 389, 599-603.
10. Davies, J., Evans, R.H., Jones, A.W., Smith, D.A. & Watkins, J.C. (1982). Differential activation and blockade of excitatory amino acid receptors in the mammalian and amphibian central nervous systems. Comp. Biochem. Physiol., 72 (Suppl), C211-C224).
11. Evans, R.H., Jones, A.W. & Watkins, J.C. (1980). Willardiine: A potent quisqualate-like excitant. J. Physiol., 308, 71-72P.
12. Evans, R.H., Francis, A.A., Jones, A.W., Smith, D.A.S. & Watkins, J.C. (1982). The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br. J. Pharmacol., 75, 65-75.
13. Fitzjohn, S.M., Bortolotto, Z.A., Palmer, M.J., Doherty, M.J., Doherty, A.J., Ornstein, P.L., Schoepp, D.D., Kingston, A.E., Lodge, D. & Collingridge, G.L. (1998). The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology, 37, 1445-1458.
14. Fletcher, E.J. & Lodge, D. (1996). New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacology and Therapeutics, 70, 65-89.
15. Honoré, T., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. & Nielsen, F.E. (1988). Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science, 241, 701-703.
16. Jane, D.E. (2002). Antagonists acting at the NMDA receptor complex: Potential for therapeutic applications. In Glutamate and GABA Receptors and Transporters. Eds Krogsgaard-Larsen, P., Egebjerg, J., Schousboe, A. pp. 69-98. London: Taylor & Francis.
17. Jane, D.E., Hoo, K., Kamboj, R., Deverill, M., Bleakman, D. & Mandelzys, A. (1997). Synthesis of willardiine and 6-azawillardiine analogs: Pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J. Med. Chem., 40, 3645-3650.
18. Jane, D.E., Jones, P.L., St. J., Pook, P.C.-K., Tse, H.-W. & Watkins, J.C. (1994). Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord. Br. J. Pharmacol., 112, 809-816.
19. Jane, D.E., Tse, H.-W., Skifter, D.A., Christie, J.M. & Monaghan, D.T. (2000). Glutamate receptor ion channels: Activators and inhibitors. In: Pharmacology of Ionic Channel Function: Activators and Inhibitors. Eds Endo, M., Kurachi, Y., Mishina, M. pp. 415-459. Berlin: Springer-Verlag.
20. Jones, S.C., Troop, H.M., Jane, D.E. & Roberts, P.J. (2001). Pharmacological characterization of novel AMPA receptor ligands in rat brain. Br. J. Pharmacol., 134, 145P.
21. Krogsgaard-Larsen, P., Ferkany, J.W., Nielson, E.Ø., Madsen, U., Ebert, B., Johansen, J.S., Diemer, N.H., Bruhn, T., Beattie, D.T. & Curtis, D.R. (1991). Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection. J. Med. Chem., 34, 123-130.
22. Long, S.K., Evans, R.H., Cull, L., Krijzer, F. & Bevan, P. (1988). An in vitro mature spinal cord preparation from the rat. Neuropharmacology, 27, 541-546.
23. Long, S.K., Smith, D.A.S., Siarey, R.J. & Evans, R.H. (1990). Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurones in vitro. Br. J. Pharmacol., 100, 850-854.
24. Madsen, U., Bang-andersen, B., Brehm, L., Christensen, I.T., Ebert, B., Kristoffersen, Y.L. & Krogsgaard-Larsen, P. (1996). Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists. J. Med. Chem., 39, 1682-1691.
25. Miller, J.C., More, J.C.A., Howson, P.A. & Jane, D.E. (2000). Pharmacological identification of mGlu1 and mGlu5 group I metabotropic receptor subtypes on neonatal rat motoneurones. Br. J. Pharmacol., 129, 103P.
26. 3-substituted willardiine analogue (S)-3-(4-carboxybenzyl)willardiine selectively antagonises AMPA over kainate receptors on neonatal rat spinal motoneurones. Br. J. Pharmacol., 133, 152P.
27. 3-substituted willardiine analogues act as kainate receptor antagonists in the neonatal rat dorsal root preparation. Br. J. Pharmacol., 135, 86P.
28. O'Neill, M.J., Bond, A., Ornstein, P.L., Ward, M.A., Hicks, C.A., Hoo, K., Bleakman, D. & Lodge, D. (1998). Decahydroisoquinolines: Novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology, 37, 1211-1222.
29. Partin, K.M., Patneau, D.K., Winters, C.A., Mayer, M.L. & Buonanno, A. (1993). Selective modulation of desensitisation at AMPA versus kainate receptors by cyclothiazide and concanavlin A. Neuron, 11, 1069-1082.
30. Patneau, D.K., Mayer, M.L., Jane, D.E. & Watkins, J.C. (1992). Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J. Neurosci., 12, 595-606.
31. Pook, P., Burgger, F., Hawkins, N.S., Clark, K.C., Watkins, J.C. & Evans, R.H. (1993). A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. Br. J. Pharmacol., 108, 179-184.
32. Schoepp, D.D., Jane, D.E. & Monn, J.A. (1999). Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology, 38, 1431-1476.
33. Schoepp, D.D., Lodge, D., Bleakman, D., Leander, J.D., Tizzano, J.P., Wright, R.A., Palmer, A.J., Salhoff, C.R. & Ornstein, P.L. (1995). In vitro and in vivo antagonism of AMPA receptor activation by (3S,4aR,6R,8aR)-6-[2-(1-2H-tetrazole-5-yl)ethyl]decahydroisoquinoiline-3- carboxylic acid. Neuropharmacology, 34, 1159-1168.
34. Sheardown, M.J., Nielsen, E.Ø., Hansen, A.J., Jacobsen, P. & Honore, T. (1990). 2,3-Dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science, 247, 571-574.
35. Simmons, R.M.A., Li, D.L., Moo, K.H., Deverill, M., Ornstein, P.L. & Iyengar, S. (1998). Kainate GluR5 receptor mediates the nociceptive response to formalin in the rat. Neuropharmacology, 37, 25-36.
36. Stegenga, S.L. & Kalb, R.G. (2001). Developmental regulation of N-methyl-D-aspartate- and kainate-type glutamate receptor expression in the rat spinal cord. Neuroscience, 105, 499-507.
37. Swanson, G.T., Green, T. & Heinemann, S.F. (1998). Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardiine. Mol. Pharmacol., 53, 942-949.
38. Thomas, N.K., Clayton, P. & Jane, D.E. (1997). Dicarboxyphenylglycines as selective antagonists of AMPA-induced depolarizations in neonatal rat motoneurones. Eur. J. Pharmacol., 338, 111-116.
39. Thomas, N.K., Hawkins, L.M., Miller, J.C., Troop, H.M., Roberts, P.J. & Jane, D.E. (1998). Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots. Neuropharmacology, 37, 1223-1237.
40. Tölle, T.R., Berthele, A., Zieglgansberger, W., Seeburg, P.H. & Wisden, W. (1993). The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci., 13, 5009-5028.
41. Varney, M.A., Rao, S.P., Jachec, C., Deal, C., Hess, S.D., Daggett, L.P., Lin, F.F., Johnson, E.C. & Veliçelebi, G. (1998). Pharmacological characterization of the human ionotropic glutamate receptor subtype GIuR3 stably expressed in mammalian cells. J. Pharmacol. Exp. Ther., 285, 358-370.
42. Watkins, J.C. & Collingridge, G.L. (1994). Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci., 15, 333-342.
43. Watkins, J.C. & Evans, R.H. (1981). Excitatory amino acid transmitters. Ann. Rev. Pharmacol., 21, 165-204.
44. Watkins, J.C., Krogsgaard-Larsen, P. & Honoré, T. (1990). Structure-activity relationships in the development of excitatory amino acid receptor agonlsts and competitive agonists. Trends Pharmacol. Sci., 11, 25-33.
45. Wilding, T.J. & Huettner, J.E. (1995). Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol., 47, 582-587.
46. Wong, L.A., Mayer, M.L., Jane, D.E. & Watkins, J.C. (1994). Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurones. J. Neurosci., 14, 3881-3897.
47. Zeman, S. & Lodge, D. (1992). Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Br. J. Pharmacol., 186, 367-372.